Something old, something new, PET in adrenal imaging Milton D. GrossDomenico Rubello Editorial 13 March 2008 Pages: 1233 - 1235
Consolidation radioimmunotherapy of follicular lymphoma: a step towards cure? Jean-François ChatalFrançoise Kraeber-BodéréJacques Barbet Editorial 11 March 2008 Pages: 1236 - 1239
188Re-labelled gemcitabine/bisphosphonate (Gem/BP): a multi-functional, bone-specific agent as a potential treatment for bone metastases Amal A. El-MabhouhJohn R. Mercer Original Article 12 February 2008 Pages: 1240 - 1248
Therapy of human carcinoma xenografts with antibodies to EGFr and HER-2 conjugated to radionuclides emitting low-energy electrons M. Jules MattesDavid M. Goldenberg Original Article 12 February 2008 Pages: 1249 - 1258
Clinical effects of transcatheter hepatic arterial embolization with holmium-166 poly(l-lactic acid) microspheres in healthy pigs M. A. D. VenteJ. F. W. NijsenA. D. van het Schip Original Article Open access 11 March 2008 Pages: 1259 - 1271
The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer Michael J. WillhauckBibi-Rana Sharif SamaniChristine Spitzweg Original Article 11 April 2008 Pages: 1272 - 1281
Determination of tumour hypoxia with [18F]EF3 in patients with head and neck tumours: a phase I study to assess the tracer pharmacokinetics, biodistribution and metabolism P. MahyX. GeetsV. Grégoire Original Article 04 March 2008 Pages: 1282 - 1289
Could 99mTc-glucarate be used to evaluate tumour necrosis? Nathalie PerekOdile SabidoFrancis Dubois Original article 13 March 2008 Pages: 1290 - 1298
Staging the Axilla with selective sentinel node biopsy in patients with previous excision of non-palpable and palpable breast cancer R. RuanoM. RamosM. C. Macias Original Article 12 February 2008 Pages: 1299 - 1304
18F-FDG PET for the lymph node staging of non-small cell lung cancer in a tuberculosis-endemic country: Is dual time point imaging worth the effort? Ruoh-Fang YenKe-Cheng ChenYung-Chie Lee Original Article 19 February 2008 Pages: 1305 - 1315
Role of [18F]FDG-PET/CT after radiofrequency ablation of liver metastases: preliminary results Laura L. TravainiGiuseppe TrifiròGiovanni Paganelli Original Article 13 March 2008 Pages: 1316 - 1322
The use of 18F-FDG PET/CT in colorectal liver metastases—comparison with CT and liver MRI G. KongC. JacksonG. J. R. Cook Original Article 18 March 2008 Pages: 1323 - 1329
Is absolute quantification of dopaminergic neurotransmission studies with 123I SPECT ready for clinical use? Habib ZaidiGeorges El Fakhri Editorial Commentary 04 June 2008 Pages: 1330 - 1333
Quantification of dopaminergic neurotransmission SPECT studies with 123I-labelled radioligands. A comparison between different imaging systems and data acquisition protocols using Monte Carlo simulation Cristina CrespoJudith GallegoDomènec Ros Original Article 12 March 2008 Pages: 1334 - 1342
Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [123I]FP-CIT Andrea VarroneValeria SansoneMarco Salvatore Original Article 19 February 2008 Pages: 1343 - 1349
AMPT-induced monoamine depletion in humans: evaluation of two alternative [123I]IBZM SPECT procedures Erik BootJan BooijThérèse A. van Amelsvoort Original Article Open access 19 February 2008 Pages: 1350 - 1356
Individual cerebral metabolic deficits in Alzheimer’s disease and amnestic mild cognitive impairment: an FDG PET study Angelo Del SoleFrancesca ClericiGiovanni Lucignani Original Article 17 April 2008 Pages: 1357 - 1366
The cost effectiveness of 123I-FP-CIT SPECT imaging in patients with an uncertain clinical diagnosis of parkinsonism Koen Van LaereLudwig EveraertThierry Vander Borght Original Article 02 April 2008 Pages: 1367 - 1376
ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicine Ferid HaddadLudovic FerrerJean-François Chatal Review Article 09 May 2008 Pages: 1377 - 1387
The power of synergy in the mediastinal staging of lung cancer Giovanni Lucignani Focus on 09 May 2008 Pages: 1388 - 1391
Treatment efficacy of combined biphosphonates and 186Re-HEDP treatment in cancer patients with bone metastases John KoutsikosAnastasia Leondi Letter to the editor 26 April 2008 Pages: 1392 - 1393
Multimodality treatment in hormone-refractory prostate cancer patients with bone metastases Marnix G. E. H. LamBernard A. Zonnenberg Letter to the editor Open access 26 April 2008 Pages: 1394 - 1395
Spent Technetium-99m generator body adapted for sterilization of radioactive preparations A. Mushtaq Letter to the Editor 09 May 2008 Pages: 1396 - 1396
Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspective Paolo Zanotti-FregonaraDomenico RubelloElif Hindié Letter to the Editor 10 May 2008 Pages: 1397 - 1399
The specific case of radiopharmaceuticals and GMP—activities of the Radiopharmacy Committee C. DecristoforoP. ElsingaThe Radiopharmacy Committee of the EANM Letter to the Editor 15 May 2008 Pages: 1400 - 1401
Diffuse bone marrow uptake of 99mTc (III) DMSA in Fanconi’s anemia Sandip BasuRamesh AsopaSurendra H. Moghe Image of the month 06 May 2008 Pages: 1402 - 1402
18F-FDG PET/CT imaging in tendon xanthomatosis Dae-Weung KimChang-Guhn KimYoung Cheon Na Image of the month 20 May 2008 Pages: 1403 - 1404
EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy Michael LassmannHeribert HänscheidMarkus Luster Guidelines 20 May 2008 Pages: 1405 - 1412